Biomimetic Design of Peptide Inhibitor to Block CD47/SIRPα Interactions
Langmuir · 2023
DOI: 10.1021/acs.langmuir.3c02898 ↗Kurz gefasst
Fachartikel in der Zeitschrift Langmuir, 2023. Verfasst von Si Zheng und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemical Engineering and Frontiers Science Center for Synthetic Biology and Key Laboratory of Systems Bioengineering (MOE), School o…. Hauptthemen laut MEDLINE: CD47 Antigen, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Tianjin University, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biochemical Engineering and Frontiers Science Center for Synthetic Biology and Key Laboratory of Systems Bioengineering (MOE), School of Chemical Engineering and Technology, Tianjin University, Tianjin 300…
ORCID-Profile: Lin Zhang
Förderung
- National Key Research and Development Program of China
- Tianjin University
- National Natural Science Foundation of China
Zitieren
APA
Zheng, S., Ji, Y., Li, N., & Zhang, L. (2023). Biomimetic Design of Peptide Inhibitor to Block CD47/SIRPα Interactions. Langmuir. https://doi.org/10.1021/acs.langmuir.3c02898
Vancouver
Zheng S, Ji Y, Li N, Zhang L. Biomimetic Design of Peptide Inhibitor to Block CD47/SIRPα Interactions. Langmuir. 2023. doi:10.1021/acs.langmuir.3c02898
BibTeX
@article{Zheng2023,
author = {Zheng, Si and Ji, Yufan and Li, Nanxing and Zhang, Lin},
title = {Biomimetic Design of Peptide Inhibitor to Block CD47/SIRPα Interactions},
journal = {Langmuir},
year = {2023},
doi = {10.1021/acs.langmuir.3c02898}
}
EUVIMED